We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




World's First Open-Source Real-Time PCR Thermocycler Launched

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Image: Open qPCR, the new lower cost and world's first open-source real-time PCR thermocycler (Photo courtesy of Chai Biotechnologies).
Image: Open qPCR, the new lower cost and world's first open-source real-time PCR thermocycler (Photo courtesy of Chai Biotechnologies).
Priced at a tenth the cost of traditional cyclers, the low-cost qPCR thermocycler will especially benefit lesser-funded laboratories and can facilitate diagnostics in developing countries.

Chai Biotechnologies (Santa Clara, CA, USA), a biotech startup focused on making core molecular biological technologies more accessible while developing powerful tools for synthetic biologists, now offers Open qPCR—the world's first open-source real-time PCR thermocycler. The new relative quantitative PCR (qPCR) machine has now been launched via a KickStarter crowdfunding campaign.

As with real-time PCR used in diagnostic and research applications, Open qPCR is capable of genotyping, pathogen presence/absence detection, and relative DNA quantification. With its current 16-well sample capacity (100 µL or 200 µL tubes), it is primarily focused on diagnostics related applications.

The instrument is currently available for USD 1,499 as part of the campaign, and is expected to ship in March 2015. "With Real-Time PCR thermocyclers typically costing USD 20,000 and up, this technology was simply unaffordable to lesser funded university labs, institutes in developing countries dealing with emerging epidemics, and the growing DIYbio [do-it-yourself biology] maker-movement," said Josh Perfetto, founder and chief executive of Chai, "With Open qPCR, we've lowered the cost of the Real-Time PCR reaction by an order of magnitude." CEO Perfetto was also a co-creator of the earlier OpenPCR project, which made the world's first open-source endpoint PCR thermocycler available in 2011.

Features of Open qPCR include: Visual, web-based interface for protocol editing, plate layout, and results interpretation; Integrated touch screen supports field use; Ethernet, Wi-Fi, and USB connectivity; Open API supports automation applications; Low power mode for isothermal amplification applications; Complete hardware design and software, to be released as open source when machine ships.

The KickStarter campaign runs until December 4, 2014. The campaign is also raising funds to donate instruments to Ebola clinics in western Africa.

Related Links:

Chai Biotechnologies
Open qPCR 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.